Kamada Ltd. - Ordinary Shares (KMDA)
KMDA moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How KMDA actually reacts to news — the realized, point-in-time move the market made, measured across 185 labeled events over the last three years with zero look-ahead.
KMDA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 42% | 163 |
| 30-min | 0.00% | 44% | 183 |
| 60-min | +0.00% | 50% | 185 |
| to close | 0.00% | 50% | 185 |
| Middle 50% of KMDA reactions | -0.43% to +0.50% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 185 |
Half of all Kamada Ltd. - Ordinary Shares news events land between -0.43% and +0.50% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How KMDA reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 14 | -0.30% | 14% | +0.45% |
| Rating reiterations | 22 | +0.10% | 59% | -0.07% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how KMDA ranks against every other measured name →
That’s how KMDA usually reacts — get an email when it moves on news →Email me when KMDA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to KMDA's baseline. Nothing else.
Recent KMDA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K KAMADA LTD For: Oct 06 | SEC filing · Form 6-K | SEC EDGAR | -0.25% | +0.62% | |
| Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel | Press release | GlobeNewswire | -0.25% | +0.62% | |
| Form 6-K KAMADA LTD For: Oct 05 | SEC filing · Form 6-K | SEC EDGAR | -0.25% | +0.62% | |
| CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand | Press release | GlobeNewswire | +0.54% | +3.09% | |
| Form 6-K KAMADA LTD For: Sep 17 | SEC filing · Form 6-K | SEC EDGAR | +0.54% | +3.09% | |
| Form EFFECT KAMADA LTD | SEC filing · Form EFFECT | SEC EDGAR | +0.61% | -0.24% | |
| Form 6-K KAMADA LTD For: Sep 10 | SEC filing · Form 6-K | SEC EDGAR | +0.25% | -1.24% | |
| Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference | Press release | GlobeNewswire | +0.25% | -1.24% | |
| Form F-3 KAMADA LTD | SEC filing · Form F-3 | SEC EDGAR | -0.12% | -0.73% | |
| Form 6-K KAMADA LTD For: Sep 03 | SEC filing · Form 6-K | SEC EDGAR | +0.53% | +2.64% | |
| Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders | Press release | GlobeNewswire | +0.53% | +2.64% | |
| Form 6-K KAMADA LTD For: Aug 17 | SEC filing · Form 6-K | SEC EDGAR | +1.20% | +3.05% | |
| Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026 | Press release | GlobeNewswire | +1.20% | +3.05% | |
| Form 6-K KAMADA LTD For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +0.14% | -2.96% | |
| Kamada Announces Planned Transition of Chief Financial Officer | Press release | GlobeNewswire | +0.14% | -2.96% | |
| Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance | Press release | GlobeNewswire | +0.14% | -2.96% | |
| Form 6-K KAMADA LTD For: Aug 05 | SEC filing · Form 6-K | SEC EDGAR | +0.07% | -0.97% | |
| Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026 | Press release | GlobeNewswire | +0.07% | -0.97% | |
| Form 6-K KAMADA LTD For: Jul 20 | SEC filing · Form 6-K | SEC EDGAR | +0.69% | -2.07% | |
| Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies | Press release | GlobeNewswire | +0.69% | -2.07% | |
| Form 6-K KAMADA LTD For: Jul 13 | SEC filing · Form 6-K | SEC EDGAR | +0.85% | +1.85% | |
| Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting | Press release | GlobeNewswire | +0.85% | +1.85% | |
| Form 6-K KAMADA LTD For: Jun 18 | SEC filing · Form 6-K | SEC EDGAR | -0.55% | -0.41% | |
| Form 6-K KAMADA LTD For: Jun 01 | SEC filing · Form 6-K | SEC EDGAR | -0.13% | -0.26% | |
| Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory | Press release | GlobeNewswire | -0.13% | -0.26% | |
| Form 6-K KAMADA LTD For: Mar 31 | SEC filing · Form 6-K | SEC EDGAR | -3.01% | -1.01% | |
| Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year | Press release | GlobeNewswire | -3.01% | -1.01% | |
| Form 6-K KAMADA LTD For: May 06 | SEC filing · Form 6-K | SEC EDGAR | -0.36% | -0.48% | |
| Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026 | Press release | GlobeNewswire | -0.36% | -0.48% | |
| Form 6-K KAMADA LTD For: Mar 31 | SEC filing · Form 6-K | SEC EDGAR | +0.48% | +3.73% | |
| Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders | Press release | GlobeNewswire | +0.48% | +3.73% | |
| Form 6-K KAMADA LTD For: Mar 26 | SEC filing · Form 6-K | SEC EDGAR | +0.12% | +0.98% | |
| Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas | Press release | GlobeNewswire | +0.12% | +0.98% | |
| Form 6-K KAMADA LTD For: Mar 17 | SEC filing · Form 6-K | SEC EDGAR | -0.45% | -3.05% | |
| Form 20-F KAMADA LTD For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | -0.69% | -1.72% | |
| Form 6-K KAMADA LTD For: Mar 11 | SEC filing · Form 6-K | SEC EDGAR | -0.69% | -1.72% | |
| Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy | Press release | GlobeNewswire | -0.69% | -1.72% | |
| Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth | Press release | GlobeNewswire | -0.69% | -1.72% | |
| Form 6-K KAMADA LTD For: Mar 04 | SEC filing · Form 6-K | SEC EDGAR | -0.11% | +0.99% | |
| Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026 | Press release | GlobeNewswire | -0.11% | +0.99% | |
| Form 6-K KAMADA LTD For: Jan 07 | SEC filing · Form 6-K | SEC EDGAR | -0.20% | -2.12% | |
| Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance | Press release | GlobeNewswire | -0.20% | -2.12% | |
| Form 6-K KAMADA LTD For: Dec 18 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -0.14% | |
| Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender | Press release | GlobeNewswire | +0.00% | -0.14% | |
| Form 6-K KAMADA LTD For: Dec 10 | SEC filing · Form 6-K | SEC EDGAR | -0.14% | +1.88% | |
| Form 6-K KAMADA LTD For: Dec 08 | SEC filing · Form 6-K | SEC EDGAR | -0.44% | -0.30% | |
| Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026 | Press release | GlobeNewswire | -0.44% | -0.30% | |
| Form 6-K/A KAMADA LTD For: Dec 02 | SEC filing · Form 6-K | SEC EDGAR | -0.72% | -0.86% | |
| Form 6-K KAMADA LTD For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | -0.14% | -1.13% | |
| Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability Growth | Press release | GlobeNewswire | -0.14% | -1.13% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the KMDA section they belong to.
Where else KMDA is measured.
KMDA earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SUNNIVA INC (SNNVF) | 186 | 0.00% | 37% |
| CHOOM HLDGS INC (CHOOF) | 185 | -0.11% | 48% |
| VACCINEX INC (VCNX) | 185 | 0.00% | 48% |
| CONVATEC GRP PLC UNSP/ADR (CNVVY) | 184 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Kamada Ltd. - Ordinary Shares's median reaction calculated?
Every labeled KMDA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 185 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of KMDA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does KMDA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.